Defective monocyte killing in cancer patients.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007165:Immunosuppression Therapy; D009000:Monocytes / Q000187:drug effects* / Q000276:immunology; D009369:Neoplasms / Q000276:immunology*
D000970:Antineoplastic Agents